| Kronox Lab Sciences Ltd | Industry : (Chemicals) | |
|---|---|---|
|
BSE Code : 544187 |
NSE Symbol : KRONOX |
P/E(TTM) : 27.97 |
|
ISIN Demat : INE0ATZ01017 |
Div & Yield% : 0.23 |
EPS(TTM) : 7.70 |
|
Book Value(₹) : 31.30 |
Market Cap(₹Cr) : 799.03 |
Face Value(₹) : 10.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 28.39 | 26.13 | 25.27 | 25.53 | 24.29 | 26.13 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 28.39 | 26.13 | 25.27 | 25.53 | 24.29 | 26.13 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 1.30 | 2.15 | 1.13 | 1.04 | 0.87 | 0.91 |
| Total Income | 29.68 | 28.27 | 26.41 | 26.58 | 25.16 | 27.05 |
| Total Expenditure | 19.39 | 16.61 | 17.25 | 16.89 | 16.32 | 18.38 |
| PBIDT | 10.30 | 11.67 | 9.16 | 9.69 | 8.84 | 8.66 |
| Interest | 0.03 | 0.04 | 0.04 | 0.04 | 0.00 | 0.00 |
| PBDT | 10.26 | 11.63 | 9.12 | 9.65 | 8.84 | 8.66 |
| Depreciation | 0.45 | 0.66 | 0.52 | 0.47 | 0.40 | 0.35 |
| Tax | 2.53 | 2.96 | 2.07 | 2.50 | 2.19 | 2.17 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.02 | 0.00 | -0.06 | 0.00 | -0.02 | -0.17 |
| Reported Profit After Tax | 7.30 | 8.00 | 6.59 | 6.68 | 6.28 | 6.32 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 7.30 | 8.00 | 6.59 | 6.68 | 6.28 | 6.32 |
| EPS (Unit Curr.) | 2.00 | 2.18 | 1.79 | 1.82 | 1.70 | 1.72 |
| EPS (Adj) (Unit Curr.) | 2.00 | 2.18 | 1.79 | 1.82 | 1.70 | 1.72 |
| Calculated EPS (Unit Curr.) | 1.97 | 2.16 | 1.78 | 1.80 | 1.69 | 1.70 |
| Calculated EPS (Adj) (Unit Curr.) | 1.97 | 2.16 | 1.78 | 1.80 | 1.69 | 1.70 |
| Calculated EPS (Ann.) (Unit Curr.) | 7.87 | 8.63 | 7.10 | 7.20 | 6.77 | 6.81 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 7.87 | 8.63 | 7.10 | 7.20 | 6.77 | 6.81 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 37.10 | 37.10 | 37.10 | 37.10 | 37.10 | 37.10 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 36.28 | 44.66 | 36.25 | 37.96 | 36.39 | 33.14 |
| PBDTM(%) | 36.14 | 44.51 | 36.09 | 37.80 | 36.39 | 33.14 |
| PATM(%) | 25.71 | 30.62 | 26.08 | 26.17 | 25.85 | 24.19 |
